Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
Stockhammer
G
G
Sandoz Pharma, Ltd., Basel, Switzerland.
Brotchi
J
J
Leblanc
R
R
Bernstein
M
M
Schackert
G
G
Weber
F
F
Ostertag
C
C
Mulder
N H
NH
Mellstedt
H
H
Seiler
R
R
Yonekawa
Y
Y
Twerdy
K
K
Kostron
H
H
De Witte
O
O
Lambermont
M
M
Velu
T
T
Laneuville
P
P
Villemure
J G
JG
Rutka
J T
JT
Warnke
P
P
Laseur
M
M
Mooij
J J
JJ
Boëthius
J
J
Mariani
L
L
Gianella-Borradori
A
A
D000963:Antimetabolites / Q000627:therapeutic use*; D002985:Clinical Protocols; D015774:Ganciclovir / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D005909:Glioblastoma / Q000235:genetics / Q000628:therapy*; D006801:Humans; D018139:Simplexvirus / Q000201:enzymology / Q000235:genetics; D013937:Thymidine Kinase / Q000235:genetics*
D000963:Antimetabolites; D013937:Thymidine Kinase; D015774:Ganciclovir